Regulatory submissions are more complex and resource-intensive than ever. For companies bringing new therapies and medical innovations to market, the regulatory process can be a major bottleneck.
It is not a one-time problem to solve but a constantly morphing puzzle with evolving guidelines, regional differences and exponentially growing volumes of data.
However, artificial intelligence is emerging as a powerful tool to help transform how regulatory submissions are built, reviewed and, most importantly, maintained.
Check out the rest of the feature here
